Swiss National Bank
SLXP

Swiss National Bank’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Swiss National Bank’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-96,800
Closed -$16.7M – 2643
2015
Q1 		$16.7M Buy
96,800
+37,000
+62% +$5.43M 0.04% 424
2014
Q4 		$6.87M Sell
59,800
-9,400
-14% -$1.14M 0.03% 574
2014
Q3 		$10.8M Sell
69,200
-1,100
-2% -$159K 0.04% 405
2014
Q2 		$8.67M Hold
70,300
– – 0.03% 481
2014
Q1 		$7.28M Buy
70,300
+16,300
+30% +$1.67M 0.03% 527
2013
Q4 		$4.86M Buy
54,000
+300
+0.6% +$23.9K 0.02% 632
2013
Q3 		$3.59M Sell
53,700
-1,200
-2% -$82.7K 0.02% 706
2013
Q2 		$3.63M Buy
+54,900
New +$3.14M 0.02% 692

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Swiss National Bank's SLXP Position: Q2 2015 in Review

Swiss National Bank sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 96,800 shares — an estimated $16.7M sold.

Swiss National Bank first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $16.7M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Swiss National Bank reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Swiss National Bank sold 96,800 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $16.7M.
  • Swiss National Bank first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Swiss National Bank's SALIX PHARMACEUTICALS LTD DEL position peaked at $16.7M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Swiss National Bank's 13F filing for Q2 2015, filed 5 Aug 2015.